INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 124 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,964,000 | +63.0% | 398,345 | +36.6% | 0.08% | +48.1% |
| Q4 2017 | $1,205,000 | +27.2% | 291,713 | +95.3% | 0.05% | +5.9% |
| Q3 2017 | $947,000 | -16.6% | 149,385 | +3.1% | 0.05% | -45.7% |
| Q2 2017 | $1,136,000 | +34.8% | 144,859 | +13.7% | 0.09% | +11.9% |
| Q1 2017 | $843,000 | +14.4% | 127,375 | +20.0% | 0.08% | -5.6% |
| Q4 2016 | $737,000 | +24.7% | 106,147 | +67.5% | 0.09% | +12.7% |
| Q3 2016 | $591,000 | +0.9% | 63,383 | 0.0% | 0.08% | -3.7% |
| Q2 2016 | $586,000 | -68.1% | 63,383 | -70.0% | 0.08% | -27.4% |
| Q1 2016 | $1,838,000 | +143.1% | 210,984 | +87.5% | 0.11% | +17.7% |
| Q4 2015 | $756,000 | – | 112,524 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |